• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个患有慢性B1型GM2神经节苷脂贮积症变异型的葡萄牙家庭的临床、酶学和分子特征分析

Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.

作者信息

Ribeiro M G, Sonin T, Pinto R A, Fontes A, Ribeiro H, Pinto E, Palmeira M M, Sá Miranda M C

机构信息

Instituto de Genética Médica Jacinto de Magalhães, Unidade de Enzimologia, Porto, Portugal.

出版信息

J Med Genet. 1996 Apr;33(4):341-3. doi: 10.1136/jmg.33.4.341.

DOI:10.1136/jmg.33.4.341
PMID:8730294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1050588/
Abstract

Mutations in the hexosaminidase A gene (HEXA) causing the B1 variant of GM2-gangliosidosis result in the presence of a mutant enzyme protein with a catalytically defective alpha subunit. A rare and panethnically distributed mutation, transition G533A (Arg178His), is known to be a common allele among Portuguese patients with the subacute phenotype. We now report the presence of an Arg178His allele in three Portuguese sibs with a chronic form of the disease, who carry the transition G755A (Arg252His) on the second allele. This novel mutation is the first B1 allele to be associated with an adult phenotype.

摘要

己糖胺酶A基因(HEXA)的突变导致GM2神经节苷脂贮积症B1型,产生一种具有催化缺陷α亚基的突变酶蛋白。一种罕见且全人种分布的突变,即G533A转换(Arg178His),已知是葡萄牙亚急性表型患者中的常见等位基因。我们现在报告在三名患有慢性疾病形式的葡萄牙同胞中存在Arg178His等位基因,他们的第二个等位基因携带G755A转换(Arg252His)。这种新突变是第一个与成人表型相关的B1等位基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/f91868e08607/jmedgene00258-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/1e37644de182/jmedgene00258-0077-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/6beb8bfd148c/jmedgene00258-0077-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/13fe84cb1d95/jmedgene00258-0078-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/f91868e08607/jmedgene00258-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/1e37644de182/jmedgene00258-0077-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/6beb8bfd148c/jmedgene00258-0077-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/13fe84cb1d95/jmedgene00258-0078-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/1050588/f91868e08607/jmedgene00258-0079-a.jpg

相似文献

1
Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.一个患有慢性B1型GM2神经节苷脂贮积症变异型的葡萄牙家庭的临床、酶学和分子特征分析
J Med Genet. 1996 Apr;33(4):341-3. doi: 10.1136/jmg.33.4.341.
2
Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.由β-己糖胺酶α亚基第499位或504位的精氨酸被组氨酸替代引起的青少年GM2神经节苷脂沉积症。
J Biol Chem. 1990 Jun 5;265(16):9452-7.
3
Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.迟发性GM2神经节苷脂沉积症的生化与分子层面:以B1变异型为原型
Dev Neurosci. 1991;13(4-5):288-94. doi: 10.1159/000112175.
4
Mutation in GM2-gangliosidosis B1 variant.GM2神经节苷脂贮积症B1变异型中的突变
J Neurochem. 1988 Jan;50(1):316-8. doi: 10.1111/j.1471-4159.1988.tb13266.x.
5
Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.阿什肯纳兹犹太裔患者成人型和慢性GM2神经节苷脂贮积症的分子基础:β-己糖胺酶α亚基第269位的甘氨酸被丝氨酸取代。
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2413-7. doi: 10.1073/pnas.86.7.2413.
6
Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.与GM2神经节苷脂贮积症AB变异型相关的Cys138Arg替代的生化特征:β-己糖胺酶A识别GM2激活剂/GM2神经节苷脂复合物需要Cys138的证据。
Biochemistry. 1998 Jan 20;37(3):814-21. doi: 10.1021/bi971211s.
7
Thermodynamic characterisation of the mutated isoenzyme A of beta-N-acetylhexosaminidase in GM2-gangliosidosis B1 variant.GM2神经节苷脂贮积症B1变异型中β-N-乙酰己糖胺酶突变同工酶A的热力学特征
Clin Chim Acta. 1999 Jul;285(1-2):45-51. doi: 10.1016/s0009-8981(99)00086-8.
8
Biochemical consequences of mutations causing the GM2 gangliosidoses.导致GM2神经节苷脂贮积症的突变的生化后果。
Biochim Biophys Acta. 1999 Oct 8;1455(2-3):105-38. doi: 10.1016/s0925-4439(99)00074-5.
9
Biochemical characterization of beta-hexosaminidase in different biological specimens from eleven patients with GM2-gangliosidosis B1 variant.
J Inherit Metab Dis. 1991;14(5):715-20. doi: 10.1007/BF01799940.
10
Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
Dev Neurosci. 1991;13(4-5):295-8. doi: 10.1159/000112200.

引用本文的文献

1
Identification of novel variants in a large cohort of children with Tay-Sachs disease: An initiative of a multicentric task force on lysosomal storage disorders by Government of India.在一个大型泰萨二氏病患儿队列中鉴定新的变异:印度政府多中心溶酶体贮积症工作组的一项倡议。
J Hum Genet. 2019 Oct;64(10):985-994. doi: 10.1038/s10038-019-0647-8. Epub 2019 Aug 6.
2
Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling.使用计算机工具和同源建模对神经节苷脂贮积症突变进行基因型-表型关联分析
Mol Genet Metab Rep. 2019 Jul 17;20:100495. doi: 10.1016/j.ymgmr.2019.100495. eCollection 2019 Sep.
3

本文引用的文献

1
Collaborative study of the molecular epidemiology of Tay-Sachs disease in Europe.欧洲泰-萨克斯病分子流行病学的协作研究。
Eur J Hum Genet. 1993;1(3):229-38. doi: 10.1159/000472416.
2
Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.小鼠β-己糖胺酶基因Hexa和Hexb的结构与表达
Genomics. 1994 Jun;21(3):588-96. doi: 10.1006/geno.1994.1318.
3
Tay-Sachs disease: intron 7 splice junction mutation in two Portuguese patients.
Biochim Biophys Acta. 1995 Jan 25;1270(1):44-51. doi: 10.1016/0925-4439(94)00070-7.
Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.
GM2神经节苷脂贮积症的伴侣蛋白疗法:乙胺嘧啶对桑德霍夫成纤维细胞中β-己糖胺酶活性的影响
Mol Neurobiol. 2014 Aug;50(1):159-67. doi: 10.1007/s12035-013-8605-5. Epub 2013 Dec 20.
4
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.青少年或亚急性GM2神经节苷脂沉积症的自然病史:21例新病例及对134例既往报道病例的文献综述
Pediatrics. 2006 Nov;118(5):e1550-62. doi: 10.1542/peds.2006-0588. Epub 2006 Oct 2.
5
Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.日本患者中GM2神经节苷脂贮积症B型的不同减毒表型,这些患者在密码子499处存在HEXA突变,以及导致婴儿急性型的五个新突变。
J Hum Genet. 2003;48(11):571-4. doi: 10.1007/s10038-003-0080-9. Epub 2003 Oct 18.
4
Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.GM2神经节苷脂贮积症变异型,其中己糖胺酶A的底物特异性发生严重改变。
EMBO J. 1983;2(7):1201-5. doi: 10.1002/j.1460-2075.1983.tb01567.x.
5
Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.人β-己糖胺酶A上两个不同活性位点的证据。GM2激活蛋白与β-己糖胺酶A的相互作用。
J Biol Chem. 1985 Jun 25;260(12):7568-72.
6
Molecular cloning of the cDNA which encodes beta-N-acetylhexosaminidase A from Dictyostelium discoideum. Complete amino acid sequence and homology with the human enzyme.
J Biol Chem. 1988 Nov 15;263(32):16823-9.
7
Intermediate forms of human beta-N-acetylhexosaminidase lack activity towards 4-methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate.人β-N-乙酰己糖胺酶的中间形式对4-甲基伞形酮基β-N-乙酰氨基葡萄糖苷6-硫酸盐缺乏活性。
Biochem J. 1987 Jun 15;244(3):801-4. doi: 10.1042/bj2440801.
8
Mutation in GM2-gangliosidosis B1 variant.GM2神经节苷脂贮积症B1变异型中的突变
J Neurochem. 1988 Jan;50(1):316-8. doi: 10.1111/j.1471-4159.1988.tb13266.x.
9
Human beta-hexosaminidase alpha chain: coding sequence and homology with the beta chain.人β-己糖胺酶α链:编码序列及其与β链的同源性。
Proc Natl Acad Sci U S A. 1985 Dec;82(23):7830-4. doi: 10.1073/pnas.82.23.7830.
10
Juvenile GM2 gangliosidosis variant B1: clinical and biochemical study in seven patients.
Neuropediatrics. 1990 Feb;21(1):18-23. doi: 10.1055/s-2008-1071451.